Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

by Giancarlo Comi, Mark S. Freedman, José E. Meca-Lallana, Patrick Vermersch, Byoung Joon Kim, Alexander Parajeles, Keith R. Edwards, Ralf Gold, Houari Korideck, Jeffrey Chavin, Elizabeth M. Poole, Patricia K. Coyle
Published 2020-10-01

Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis

by Naresh Mutukula, Zhiqiu Man, Yuta Takahashi, Francisca Iniesta Martinez, Mariana Morales, Ester Carreon-Guarnizo, Rocio Hernandez Clares, David Garcia-Bernal, Llanos Martinez Martinez, Jeronimo Lajara, Estrella Nuñez Delicado, Jose E. Meca Lallana, Juan Carlos Izpisua Belmonte
Published 2021-05-01

Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.

by José E Meca-Lallana, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L Martínez-Ginés, Inés González-Suárez, Sabas Boyero, Lucía Romero-Pinel, Ángel P Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi, Rocío Gómez-Ballesteros, Javier Ballesteros
Published 2021-01-01